SGM
CAI

Seven Grand Managers’s Caris Life Sciences CAI Stock Holding History

Seven Grand Managers’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-495,095
Closed -$13.4M – 207
2025
Q4 		$13.4M Buy
495,095
+395,095
+395% +$11.1M 1.02% 28
2025
Q3 		$3.02M Buy
100,000
+50,000
+100% +$1.59M 0.25% 79
2025
Q2 		$1.34M Buy
+50,000
New +$1.35M 0.16% 57

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Seven Grand Managers's CAI Position: Q1 2026 in Review

Seven Grand Managers sold out of Caris Life Sciences (CAI) in Q1 2026, closing a stake of 495,095 shares — an estimated $13.4M sold.

Seven Grand Managers first reported a position in CAI in Q2 2025 and held it in 3 quarters. The position peaked at $13.4M in Q4 2025. 202 funds tracked by Wall St. Rank hold CAI as of Q1 2026.

  • Seven Grand Managers reported no remaining Caris Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Seven Grand Managers sold 495,095 Caris Life Sciences shares in Q1 2026, an estimated $13.4M.
  • Seven Grand Managers first reported a position in Caris Life Sciences in Q2 2025 and held it in 3 quarters.
  • Seven Grand Managers's Caris Life Sciences position peaked at $13.4M in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Caris Life Sciences as of Q1 2026.

Based on Seven Grand Managers's 13F filing for Q1 2026, filed 6 May 2026.